| Generic name: | Semaglutide |
| Cas No.: | 910463-68-2 |
| Molecular Formula: | C187H291N45O59 |
| Molecular weight: | 4113.641 g/mol |
| Sequence: | -His-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys(AEEAc-AEEAc-γ-Glu-17-carboxyheptadecanoyl)-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg-Gly-OH |
| Appearance: | White powder |
| Application: | Semaglutide is a medicine used to treat type 2 diabetes. It belongs to a class of drugs called GLP-1 receptor agonists, which work by increasing insulin secretion and decreasing glucose production in the liver. Semaglutide is injected once a week and has been shown in clinical trials to effectively lower blood sugar levels. Additionally, it has been associated with weight loss and improved cardiovascular outcomes. Semaglutide is generally well tolerated, but some patients may experience side effects such as nausea, vomiting or diarrhea. Patients should discuss all potential side effects and risks with their healthcare provider before taking semaglutide. It is important to note that semaglutide should not be used to treat type 1 diabetes or diabetic ketoacidosis. |
| Package: | aluminium foil bag or aluminium TIN or as per customer’s requirements |
|
1 |
Professional supplier for peptide APIs from China. |
|
2 |
16 production lines with enough big production capacity with competitive price |
|
3 |
GMP and DMF available with most reliable documentation. |